177 related articles for article (PubMed ID: 16957652)
21. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin use in giant cell bone tumors.
Nouri H; Hedi Meherzi M; Ouertatani M; Mestiri M; Zehi K; Douik M; Zouari M
Orthop Traumatol Surg Res; 2011 Sep; 97(5):520-6. PubMed ID: 21723215
[TBL] [Abstract][Full Text] [Related]
23. Giant cell tumor of bone.
Mendenhall WM; Zlotecki RA; Scarborough MT; Gibbs CP; Mendenhall NP
Am J Clin Oncol; 2006 Feb; 29(1):96-9. PubMed ID: 16462511
[TBL] [Abstract][Full Text] [Related]
24. Giant cell tumours of bone. A DNA-flow cytometric study.
Heliö H; Karaharju E; Böhling T; Nordling S
Eur J Surg Oncol; 1994 Jun; 20(3):200-6. PubMed ID: 8181593
[TBL] [Abstract][Full Text] [Related]
25. [Giant-cell tumor of bone: a review of diagnosis and treatment of 105 cases].
Liu P; Tao S; Xia K
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):313-5. PubMed ID: 11038769
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
27. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
[TBL] [Abstract][Full Text] [Related]
28. Ethanol as a local adjuvant for giant cell tumor of bone.
Jones KB; DeYoung BR; Morcuende JA; Buckwalter JA
Iowa Orthop J; 2006; 26():69-76. PubMed ID: 16789453
[TBL] [Abstract][Full Text] [Related]
29. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma of the external auditory canal: long-term clinical outcomes using surgery and external-beam radiotherapy.
Prabhu R; Hinerman RW; Indelicato DJ; Morris CG; Werning JW; Vaysberg M; Amdur RJ; Kirwan J; Mendenhall WM
Am J Clin Oncol; 2009 Aug; 32(4):401-4. PubMed ID: 19398900
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of giant cell tumor of bone. Histopathological analysis of 15 cases and review of the literature.
Boutou-Bredaki S; Agapios P; Papachristou G
Adv Clin Path; 2001 Jul; 5(3):71-8. PubMed ID: 11753878
[TBL] [Abstract][Full Text] [Related]
32. Aggressive giant cell tumour of bone.
Faisham WI; Zulmi W; Halim AS; Biswal BM; Mutum SS; Ezane AM
Singapore Med J; 2006 Aug; 47(8):679-83. PubMed ID: 16865207
[TBL] [Abstract][Full Text] [Related]
33. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
[TBL] [Abstract][Full Text] [Related]
34. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
35. Relapse patterns and related prognostic factors in patients with mobile tongue cancer treated with postoperative radiotherapy.
Kamer S; Esassolak M; Demirci S; Akyildiz S; Sengul A; Yavuzer A
J BUON; 2009; 14(1):51-6. PubMed ID: 19373947
[TBL] [Abstract][Full Text] [Related]
36. Recurrence of giant cell tumors in the hand: a prospective study.
Williams J; Hodari A; Janevski P; Siddiqui A
J Hand Surg Am; 2010 Mar; 35(3):451-6. PubMed ID: 20193861
[TBL] [Abstract][Full Text] [Related]
37. The cryosurgical treatment of chondroblastoma of bone: long-term oncologic and functional results.
van der Geest IC; van Noort MP; Schreuder HW; Pruszczynski M; de Rooy JW; Veth RP
J Surg Oncol; 2007 Sep; 96(3):230-4. PubMed ID: 17443729
[TBL] [Abstract][Full Text] [Related]
38. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence.
Olson TP; Harter J; Muñoz A; Mahvi DM; Breslin T
Ann Surg Oncol; 2007 Oct; 14(10):2953-60. PubMed ID: 17674109
[TBL] [Abstract][Full Text] [Related]
39. Treatment of duodenal adenomas with endoscopic argon plasma coagulation.
Lienert A; Bagshaw PF
ANZ J Surg; 2007 May; 77(5):371-3. PubMed ID: 17497979
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant chemotherapy with doxorubicin and dacarbazine has no effect in recurrence-free survival of malignant phyllodes tumors of the breast.
Morales-Vásquez F; Gonzalez-Angulo AM; Broglio K; Lopez-Basave HN; Gallardo D; Hortobagyi GN; De La Garza JG
Breast J; 2007; 13(6):551-6. PubMed ID: 17983394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
